Brokerages Set Structure Therapeutics Inc. (NASDAQ:GPCR) Price Target at $76.50
Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) has earned a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued a report on the […]
Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) has earned a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued a report on the […]
